DNLI icon

Denali Therapeutics
DNLI

45 hedge funds and large institutions have $909M invested in Denali Therapeutics in 2017 Q4 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$322M
2
+$146M
3
+$139M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$77M
5
Temasek Holdings
Temasek Holdings
Singapore
+$69M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$624K
27
$621K
28
$487K
29
$440K
30
$249K
31
$237K
32
$228K
33
$204K
34
$188K
35
$184K
36
$166K
37
$36K
38
$34K
39
$31K
40
$27K
41
$16K
42
$4K
43
$4K
44
$3K
45
$1K
1
2